Steriwave ICU Pilot Study

NANot yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

August 4, 2025

Conditions
Ventilator Acquired PneumoniaHospital Acquired PneumoniaHospital Acquired InfectionsNasal Decolonization of Staphylococcus Aureus
Interventions
DEVICE

Antimicrobial photodynamic therapy (aPDT) nasal decolonization device

aPDT is a technique that employs a specific wavelength of light to activate a photosensitizer substance. Once activated, this photosensitizer reacts with surrounding molecules to produce radicals and reactive oxygen species. When activated in the presence of microorganisms, these molecules serve to disrupt membrane structure and protein cross-linking, leading to their death.

Trial Locations (1)

V3L 3W7

Royal Columbian Hospital, New Westminster

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Ondine Biomedical Inc.

INDUSTRY

collaborator

Royal Columbian Hospital Foundation

OTHER

lead

Fraser Health

OTHER